Search
Displaying 841–850 of 891 results for “vision connection”
-
My Retina Tracker Genetic Testing Program
The Foundation Fighting Blindness, in partnership with PreventionGenetics and InformedDNA®, offers an open access, no-cost genetic testing program called the My Retina Tracker® Genetic Testing Program.
-
Raising Our Sights DIY Fundraising FAQ
An FAQ about the opportunities for the Raising Our Sights DIY fundraising program for the Foundation Fighting Blindness.
-
FDA Approves New Wet AMD Treatment that can be Administered Every Three Months
Research NewsBeovu from Novartis reduces treatment burden for wet AMD patients
-
How Davida Regained Her Speed with Guide Dog Chubb
Beacon StoriesIn honor of National Guide Dog Month this September, Davida is sharing her experience with the Guide Dog Foundation for the Blind and how she found a perfect match in her new guide dog, Chubb.
-
Scientific Grants and Awards Programs
The Grants and Awards Programs of the Foundation Fighting Blindness support basic, laboratory-based early translational, clinical studies and pre-clinical research applicable to a broad range of retinal degenerative diseases.
-
FDA Wins Case against Stem-Cell Clinic that Blinded Patients with Bogus Treatment
Research NewsA federal court ruled that the FDA has regulatory authority over these stem-cell procedures and the power to halt them.
-
Research News
Eye Bonds provide the opportunity to advance, and accelerate development for, more promising treatments into and through clinical trials and out to the people who need them.
-
ARVO 2019: Robot-Assisted Surgery in Clinical Trial for Retinal Disease
Research NewsA video from a clinical trial of robot-assisted surgery demonstrates the potential benefits of robot-assisted subretinal injections.
-
ARVO 2019: Emerging Eloxx Molecules Show Promising Results in Usher Models
Research NewsEloxx Pharmaceuticals is developing small molecules that permit read-through of point mutations that cause Usher syndrome 1F and 2A.
-
ARVO 2019: Emerging Drug for RP Evaluated in Safety & Tolerability Study
Research NewsFrancois Paquet-Durand, PhD, chief scientific officer at the company Mireca, discusses an emerging drug for retinitis pigmentosa, and other inherited retinal diseases.
